ResMed Inc. (RMD): Price and Financial Metrics


ResMed Inc. (RMD)

Today's Latest Price: $183.03 USD

0.21 (0.11%)

Updated Oct 23 6:40pm

Add RMD to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 142 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

RMD Stock Summary

  • RMD has a market capitalization of $25,956,054,151 -- more than approximately 92.16% of US stocks.
  • Price to trailing twelve month operating cash flow for RMD is currently 32.35, higher than 87.94% of US stocks with positive operating cash flow.
  • The volatility of Resmed Inc's share price is greater than that of only 7.05% US stocks with at least 200 days of trading history.
  • Stocks that are quantitatively similar to RMD, based on their financial statements, market capitalization, and price volatility, are A, HOLX, LOGI, CERN, and VAR.
  • Visit RMD's SEC page to see the company's official filings. To visit the company's web site, go to www.resmed.com.

RMD Stock Price Chart Interactive Chart >

Price chart for RMD

RMD Price/Volume Stats

Current price $183.03 52-week high $208.99
Prev. close $182.82 52-week low $108.85
Day low $181.03 Volume 304,900
Day high $183.70 Avg. volume 674,251
50-day MA $175.85 Dividend yield 0.85%
200-day MA $170.29 Market Cap 26.52B

ResMed Inc. (RMD) Company Bio


ResMed Inc. develops, manufactures, distributes, and markets medical equipment for the diagnosis, treatment, and management of respiratory disorders with a focus on sleep-disordered breathing. The company was founded in 1989 and is based in San Diego, California.

RMD Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$183.03$73.68 -60%

We started the process of determining a valid price forecast for Resmed Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Resmed Inc ranked in the 27th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. In terms of the factors that were most noteworthy in this DCF analysis for RMD, they are:

  • The company's debt burden, as measured by earnings divided by interest payments, is 19.16; that's higher than 85.51% of US stocks in the Healthcare sector that have positive free cash flow.
  • The business' balance sheet suggests that 5% of the company's capital is sourced from debt; this is greater than only 14.6% of the free cash flow producing stocks we're observing.
  • RMD's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 44.31% of tickers in our DCF set.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-61%
1%-60%
2%-60%
3%-59%
4%-59%
5%-59%

IONS, A, ENTA, XRAY, and PKI can be thought of as valuation peers to RMD, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.


RMD Latest News Stream


Event/Time News Detail
Loading, please wait...

RMD Latest Social Stream


Loading social stream, please wait...

View Full RMD Social Stream

Latest RMD News From Around the Web

Below are the latest news stories about Resmed Inc that investors may wish to consider to help them evaluate RMD as an investment opportunity.

Digital Patient Monitoring Devices Market Size Will Accelerate Rapidly In The Near Future With Leading Key Vendors: Medtronic Plc, Omron Corporation, ResMed, AT&T, Inc, Welch Allyn, GE Healthcare, Zephyr Technology Corporation

Patient monitoring devices in this report refer to the sensors which are used in smart wearable devices. The patient monitoring devices market is driven by increasing demand for wearable for infants and continuously evolving sensor technology. With increasing personal care

OpenPR | October 2, 2020

Global Needle Guides Market Report Covers Growing Strategies Used By Top Key Players || ResMed, BD, Argon Medical Devices, Seimens

The motive of this strategic research report entitled Global Needle Guides Market Which offers company accounts, industry investors, and industry members with consequential insights to enable them to make reliable strategic decisions regarding the opportunities in the global Needle Guides

OpenPR | September 30, 2020

Global $940 Million High Performance Doors Market Outlook to 2025: Major Players are Koninklijke Philips, ResMed, Boston Scientific, Medtronic, Connect America

DUBLIN, Sept. 30, 2020 /PRNewswire/ -- The "High Performance Doors Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. The high performance doors market by revenue is expected to grow at a CAGR of approx. 4% and achieve an…

PR Newswire | September 30, 2020

MIT Leaders for Global Operations announces new industry partnership with ResMed

CAMBRIDGE, Mass., Sept. 9, 2020 /PRNewswire/ -- The MIT Leaders for Global Operations (LGO) program announced today that ResMed, a global digital health and connected medical device company, has become the newest member of its industry partnership. This addition brings the partner company…

PR Newswire | September 9, 2020

ResMed Debuts AirTouch N20 Foam CPAP Mask, Its Softest Nasal Mask Ever

SAN DIEGO--(BUSINESS WIRE)---- $RMD #CPAP--ResMed’s first nasal memory foam cushion enhances patients’ comfort and convenience, doesn’t need cleaning when replaced on an appropriate schedule.

Business Wire | September 1, 2020

Read More 'RMD' Stories Here

RMD Price Returns

1-mo 8.28%
3-mo -9.30%
6-mo 17.62%
1-year 28.08%
3-year 125.20%
5-year 243.10%
YTD 18.90%
2019 37.85%
2018 36.38%
2017 39.06%
2016 18.01%
2015 -2.29%

RMD Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full RMD Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8575 seconds.